# RadConnect Communication Application

> **NCT05540444** · — · COMPLETED · sponsor: **Philips Electronics Nederland B.V. acting through Philips CTO organization** · enrollment: 79 (actual)

## Conditions studied

- Communication

## Interventions

- **DEVICE:** RadConnect

## Key facts

- **NCT ID:** NCT05540444
- **Lead sponsor:** Philips Electronics Nederland B.V. acting through Philips CTO organization
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-29
- **Primary completion:** 2023-07-13
- **Final completion:** 2023-07-13
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2023-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05540444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05540444, "RadConnect Communication Application". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05540444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*